Assessment and management of pain in haemophilia patients

Haemophilia

Volumn 17, Issue 6, 2011, Pages 839-845

  Riley, R R ^a   Witkop, M ^a   Hellman, E ^a   Akins, S ^a  

^a Hematology Oncology of Indiana PC   (United States)

Author keywords

Chronic pain; Haemophilia; Haemophilic arthro pathy; Pain management; Pain treatment guidelines; Quality of life

Indexed keywords

ACETYLSALICYLIC ACID; ANALGESIC AGENT; CODEINE; CYCLOOXYGENASE 2 INHIBITOR; FENTANYL; HYDROCODONE; HYDROMORPHONE; METHADONE; MORPHINE; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; OXYCODONE; OXYMORPHONE; PARACETAMOL;

ACUPUNCTURE; ALTERNATIVE MEDICINE; ANALGESIA; ARTHRALGIA; ARTHROPATHY; COGNITIVE THERAPY; DRUG EFFICACY; EXERCISE; FEEDBACK SYSTEM; HEMOPHILIA; HEMOPHILIA A; HEMOPHILIA B; HERBAL MEDICINE; HUMAN; HYDROTHERAPY; HYPNOSIS; IMAGERY; INTEGRATIVE MEDICINE; INTESTINAL BLEEDING; MASSAGE; PAIN; PAIN ASSESSMENT; PATIENT ATTITUDE; PHYSICAL ACTIVITY; PHYSIOTHERAPY; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; SCORING SYSTEM; TRANSCUTANEOUS NERVE STIMULATION; HEMARTHROSIS; METHODOLOGY; PREVALENCE; UNITED KINGDOM;

GREAT BRITAIN; HEMARTHROSIS; HEMOPHILIA A; HUMANS; PAIN; PAIN MANAGEMENT; PREVALENCE;

EID: 84857956844     PISSN: 13518216     EISSN: 13652516     Source Type: Journal    
DOI: 10.1111/j.1365-2516.2011.02567.x     Document Type: Review

References (53)

1. Elander J, Barry T. Analgesic use and pain coping among patients with haemophilia. Haemophilia 2003; 9: 202-13.
2. Sherry DD. Avoiding the impact of musculoskeletal pain on quality of life in children with hemophilia. Orthop Nurs 2008; 27: 103-8.
3. Elander J, Robinson G, Mitchell K, Morris J. An assessment of the relative influence of pain coping, negative thoughts about pain, and pain acceptance on health-related quality of life among people with hemophilia. Pain 2009; 145: 169-75.
4. Mannucci PM, Schutgens RE, Santagostino E, Mauser-Bunschoten EP. How I treat age-related morbidities in elderly persons with hemophilia. Blood 2009; 114: 5256-63.
5. World Federation of Hemophila. Guidelines for the Management of Hemophilia. Quebec, Montreal: World Federation of Hemophilia, 2005.
6. Raffini L, Manno C. Modern management of haemophilic arthropathy. Br J Haematol 2007; 136: 777-87.
7. van Genderen FR, Fischer K, Heijnen L et al. Pain and functional limitations in patients with severe haemophilia. Haemophilia 2006; 12: 147-53.
8. Mauser-Bunschoten EP, Fransen Van De Putte DE, Schutgens RE. Co-morbidity in the ageing haemophilia patient: the down side of increased life expectancy. Haemophilia 2009; 15: 853-63.
9. Barr RD, Saleh M, Furlong W et al. Health status and health-related quality of life associated with hemophilia. Am J Hematol 2002; 71: 152-60.
10. Gringeri A, Mantovani LG, Scalone L, Mannucci PM, COCIS Study Group. Cost of care and quality of life for patients with hemophilia complicated by inhibitors: the COCIS study group. Blood 2003; 102: 2358-63.
11. den Uijl IE, Fischer K, Van Der Bom JG, Grobbee DE, Rosendaal FR, Plug I. Clinical outcome of moderate haemophilia compared with severe and mild haemophilia. Haemophilia 2009; 15: 83-90.
12. Wallny T, Hess L, Seuser A, Zander D, Brackmann HH, Kraft CN. Pain status of patients with severe haemophilic arthropathy. Haemophilia 2001; 7: 453-8.
13. Gourlay DL, Heit HA, Almahrezi A. Universal precautions in pain medicine: a rational approach to the treatment of chronic pain. Pain Med 2005; 6: 107-12.
14. Holstein K, Klamroth R, Perez R, Richards M, Gringeri A. European Survey on Pain Management in Patients with Hemophilia. Presented at: International Congress of the World Federation of Hemophilia; July 10-14, 2010; Buenos Aires, Argentina. Haemophilia 2010; 16(Suppl. 4): 23. [Abstract 06P22. XXIX].
15. Elander J, Robinson G. A brief haemophilia pain coping questionnaire. Haemophilia 2008; 24: 1039-48.
16. Hilliard P, Funk S, Zourikian N et al. Hemophilia joint health score reliability study. Haemophilia 2006; 12: 518-25.
17. Rosenstiel AK, Keefe FJ. The use of coping strategies in chronic low back pain patients: relationship to patient characteristics and current adjustment. Pain 1983; 17: 33-44.
18. Insall JN, Dorr LD, Scott RD, Scott WN. Rationale of the knee society clinical rating system. Clin Orthop Relat Res 1989; 248: 13-14.
19. Bellamy N, Buchanan WW, Goldsmith CH, Campbell J, Stitt LW. Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee. J Rheumatol 1988; 15: 1833-40.
20. Nahin RL, Barnes PM, Stussman BJ, Bloom B. Costs of complementary and alternative medicine (CAM) and frequency of visits to CAM practitioners: United States, 2007. Natl Health Stat Report 2009; 30: 1-14.
21. Rosted P, Jørgensen V. Acupuncture used in the management of pain due to arthropathy in a patient with haemophilia. Acupunct Med 2002; 20: 193-5.
22. Gomis M, Querol F, Gallach JE, González LM, Aznar JA. Exercise and sport in the treatment of haemophilic patients: a systematic review. Haemophilia 2009; 15: 43-54.
23. Varni JW, Gilbert A. Self-regulation of chronic arthritic pain and long-term analgesic dependence in a haemophiliac. Rheumatol Rehabil 1982; 21: 171-4.
24. Abraham J. Herbs: where's the harm? Br J Periop Nurs 2004; 9: 393-400.
25. Eslinger M. Hypnosis principles and applications: an adjunct to health care. Semin Periop Nurs 1998; 7: 39-40.
26. Liu SX, Jiang L, Liang X et al. Study on graded therapy of hemophilic arthritis by integrative traditional Chinese and Western medicine. Chin J Integr Med 2007; 13: 301-5.
27. Osiri M, Welch V, Brosseau L et al. Transcutaneous electrical nerve stimulation for knee osteoarthritis. Cochrane Database Syst Rev 2004; 4: CD002823.
28. Buzzard BM. Physiotherapy for prevention and treatment of chronic hemophilic synovitis. Clin Orthop Relat Res 1997; 343: 42-6.
29. Schilling A, Corey R, Leonard M, Eghtesad B. Acetaminophen: old drug, new warnings. Cleve Clin J Med 2010; 77: 19-27.
30. Watkins PB, Kaplowitz N, Slattery JT et al. Aminotransferase elevations in healthy adults receiving 4 grams of acetaminophen daily: a randomized controlled trial. JAMA 2006; 296: 87-93.
31. Reisine T, Pasternak G. Opioid analgesics and antagonists. In: Hardman JG, Limbird LE, Molinoff PE, Ruddon RW, Gilman AG eds. Goodman and Gilman's: The Pharmacological Basis of Therapeutics, 9th edn. New York: McGraw-Hill, 1996.
32. González EL, Patrignani P, Tacconelli S, Rodríguez LA. Variability of risk of upper gastrointestinal bleeding among non-steroidal anti-inflammatory drugs. Arthritis Rheum 2010; 62: 1592-601.
33. Lewis SC, Langman MJ, Laporte JR, Matthews JN, Rawlins MD, Wiholm BE. Dose-response relationships between individual non-aspirin non-steroidal anti-inflammatory drugs (NANSAIDs) and serious upper gastrointestinal bleeding: a meta-analysis based on individual patient data. Br J Clin Pharmacol 2002; 54: 320-6.
34. Henry D, Lim LL, Garcia Rodriguez LA et al. Variability in risk of gastrointestinal complications with individual non-steroidal anti-inflammatory drugs: results of a collaborative meta-analysis. B Med J 1996; 312: 1563-6.
35. Ofman JJ, MacLean CH, Straus WL et al. A metaanalysis of severe upper gastrointestinal complications of non-steroidal anti-inflammatory drugs. J Rheumatol 2002; 29: 804-12.
36. Langman MJ, Jensen DM, Watson DJ et al. Adverse upper gastrointestinal effects of rofecoxib compared with NSAIDs. JAMA 1999; 282: 1929-33.
37. Straube S, Tramèr MR, Moore RA, Derry S, McQuay HJ. Mortality with upper gastrointestinal bleeding and perforation: effects of time and NSAID use. BMC Gastroenterol 2009; 9: 41.
38. Watson DJ, Yu Q, Bolognese JA, Reicin AS, Simon TJ. The upper gastrointestinal safety of rofecoxib vs. NSAIDs: an updated combined analysis. Curr Med Res Opin 2004; 20: 1539-48.
39. Christensen S, Riis A, Nørgaard M, Thomsen RW, Sørensen HT. Introduction of newer selective cyclo-oxygenase-2 inhibitors and rates of hospitalization with bleeding and perforated peptic ulcer. Aliment Pharmacol Ther 2007; 25: 907-12.
40. Antman EM, Bennett JS, Daugherty A et al. Use of non-steroidal anti-inflammatory drugs: an update for clinicians: a scientific statement from the American Heart Association. Circulation 2007; 115: 1634-42.
41. Schneider V, Lévesque LE, Zhang B, Hutchinson T, Brophy JM. Association of selective and conventional non-steroidal anti-inflammatory drugs with acute renal failure: a population-based, nested case-control analysis. Am J Epidemiol 2006; 164: 881-9.
42. Eyster ME, Asaad SM, Gold BD, Cohn SE, Goederts JJ. Upper gastrointestinal bleeding in haemophiliacs: incidence and relation to use of non-steroidal anti-inflammatory drugs. Haemophilia 2007; 13: 279-86.
43. Bragadottir G, Onundarson PT. Factor-sparing use of the COX-2 inhibitor rofecoxib in haemophilic arthropathy. Haemophilia 2002; 8: 832-3.
44. Rattray B, Nugent DJ, Young G. Rofecoxib as adjunctive therapy for haemophilic arthropathy. Haemophilia 2005; 11: 240-4.
45. Tsoukas C, Eyster ME, Shingo S et al. Evaluation of the efficacy and safety of etoricoxib in the treatment of hemophilic arthropathy. Blood 2006; 107: 1785-90.
46. Trescot AM, Helm S, Hansen H et al. Opioids in the management of chronic non-cancer pain: An Update of American Society of the Interventional Pain Physicians' (ASIPP) Guidelines. Pain Physician 2008; 11(Suppl. 2): S5-62.
47. Chou R, Fanciullo GJ, Fine PG et al. Clinical guidelines for the use of chronic opioid therapy in chronic non-cancer pain. J Pain 2009; 10: 113-30.
48. Trescot AM, Datta S, Lee M, Hansen H. Opioid pharmacology. Pain Physician 2008; 11(Suppl. 2): S113-53.
49. Portenoy RK, Farrar JT, Backonja MM et al. Long-term use of controlled-release oxycodone for non-cancer pain: results of a 3-year registry study. Clin J Pain 2007; 23: 287-99.
50. Chiang CC, Chen PQ, Shen MC, Tsai W. Total knee arthroplasty for severe haemophilic arthropathy: long-term experience in Taiwan. Haemophilia 2008; 14: 828-34.
51. Habermann B, Eberhardt C, Hovy L, Zichner L, Scharrer I, Kurth AA. Total hip replacement in patients with severe bleeding disorders. A 30years single center experience. Int Orthop 2007; 31: 17-21.
52. Legroux-Gérot I, Strouk G, Parquet A, Goodemand J, Gougeon F, Duquesnoy B. Total knee arthroplasty in hemophilic arthropathy. Joint Bone Spine 2003; 70: 22-32.
53. Bae DK, Yoon KH, Kim HS, Song SJ. Total knee arthroplasty in hemophilic arthropathy of the knee. J Arthroplasty 2005; 20: 664-8.